One of the world’s most influential medical journals, the 200-year-old Lancet, has published its first paper on herbal medicine, unveiling a study on a compound that is widely used in China for ...

Use of nitazenes, a class of synthetic opioid, is rising, which experts say needs to prompt better policy. Udani Samarasekera ...

A new treatment is giving hope to people suffering from Chronic Obstructive Pulmonary Disease (COPD). Geoffrey Pointing, a 77 ...

Members of Parliament have backed a bill to legalise assisted dying in England and Wales, paving the way for a fundamental shift in doctors’ practice. Jacqui Thornton reports.

A clinical trial reveals that benralizumab, an injectable drug for severe asthma, outperforms steroids in reducing asthma and ...

The unproven 'corona drug' US is threatening India for Coronavirus: Where are cases still rising? The Lancet study involved 96,000 coronavirus patients, nearly 15,000 of whom were given ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

Correspondence to Dr Kieran O’Sullivan, Sports Spine Centre, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar; kieran.osullivan{at}aspetar.com The Lancet series of papers on low back pain ...

The trial on 62 patients, published in the Lancet, hints the medicine halted the progression of the disease. The University College London (UCL) team is "excited", but it urges caution as any long ...

The medical journal Lancet has called for immediate changes ... However there was no fault with the quality of the test drug, no contamination, no dosing error, yet the trial went wrong.